NDC Package Code : 10695-331 Start Marketing Date : 2026-01-20 End Marketing Date : 2027-12-31 Dosage Form (Strength) : POWDER (1kg/kg) Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others Anlon Healthcare manufactures high-quality Pharmaceutical Bulk Drugs & Intermediates compliant with FDA, PMDA, KFDA, cGMP & WHO-GMP
Maintaining quality sleep, consistent training, and reasonable nutrition preserves most physical improvements
Ipamorelin/CJC-1295 (no DAC) 5MG/5MG Ipamorelin/CJC-1295 (no DAC) 5MG/5MG Research Peptide Blend Research-grade peptide blend of Ipamorelin and CJC-1295 (no DAC) Supplied as a 99% pure lyophilized powder in sterile 3mL vials Must be reconstituted before use and stored properly for stability $65.00 $55.25Purchase & earn 65 points
Unfortunately, this is the potential scenario of peptide marketing and use in such an unregulated environment
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis
